SCCA Clinical Trials: Columbia Basin Hematology & Oncology
The affiliation between SCCA and Columbia Basin Hematology Oncology means patients living in southeast Washington have access to the latest cancer treatment options, including those only available in clinical trials or at a comprehensive academic cancer center, such as SCCA.
Below are the first of many SCCA clinical trials offerred for patients at Columbia Basin Hematology Oncology.
Breast Cancer (Recurrent/Metastatic)
- Triple Negative (6628)
Combined Targeted Therapies for Triple Negative Advanced Breast Cancer - A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib
- Ramucirumab for Gastric, Esophageal and GE Juntion (7575) Randomized, Placebo-Controlled, double-blind Phase 2 study of mFOLFOX6 chemotherapy plus Ramucirumab Drug Product (IMC-1121B) versus mFOLFOX6 plus placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal junction or Stomach